U-Blot® Research Grade LebrikizumabCat. No. WA3052$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LebrikizumabCat. No. WA3052
U-Blot® Research Grade lazatatugCat. No. WA3051
U-Blot® Research Grade laventatugCat. No. WA3050
U-Blot® Research Grade LatozinemabCat. No. WA3049
U-Blot® Research Grade LatikafuspCat. No. WA3048
U-Blot® Research Grade latarcibartCat. No. WA3047
U-Blot® Research Grade lasrekibartCat. No. WA3046
U-Blot® Research Grade LaronidaseCat. No. WA3045
U-Blot® Research Grade larnefpendekin alfaCat. No. WA3044
U-Blot® Research Grade LarcaviximabCat. No. WA3043
U-Blot® Research Grade LaprituximabCat. No. WA3042
U-Blot® Research Grade LanerkitugCat. No. WA3041